What are the odds of dying from a drug overdose?
Evidence quality 4.75/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 5/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 5/5
- D4 Uncertainty
- 4/5
- D5 Scope
- 5/5
- D6 Prose
- 5/5
- D7 Perception honesty
- 4/5
- D8 Caveat completeness
- 5/5
● your factors — click this risk ▾ to reveal
- Your factors
≈ As likely as
Perceived
There is no canonical "fear of dying from a drug overdose" poll the way there is for flying or being murdered. Most people do not file overdose under "things that could happen to me" at all — it is mentally shelved alongside events that happen to other people, in other neighbourhoods, after other life trajectories. The gap between that intuition and the actual US lifetime number is one of the largest on this site.
Rough estimate: most US adults would guess well under 1 in 1,000 for themselves
Source: editorial intuition, not polled
Actual
~23.3 per 100,000 per year (all ages, crude, 2024; 23.1 age-adjusted)
US residents, all ages pooled (2024)
Show derivation
Revised June 2026 to reflect the post-2023 reversal. Now uses 79,384 US drug overdose deaths in 2024 (CDC NCHS Data Brief 549, the latest complete year) against a roughly 260 million US adult population (18+, ~77% of the July 2024 resident total of 340.1 million). That yields an approximate adult-year hazard of 79,384 / 260,000,000 ≈ 0.000305 per adult-year. Compounded over 59 years of remaining adult life: 1 − (1 − 0.000305)^59 ≈ 0.0179, or about 1 in 56. This is down from the 1-in-42 figure built on the 2023 peak: the national age-adjusted rate fell 26.2% between 2023 and 2024 (31.3 → 23.1 per 100,000), the largest single-year decline NCHS has recorded, and 2025 provisional data project a further ~14% drop. The per-adult hazard remains higher than the per-capita hazard because deaths concentrate in working-age adults. Counts include all drug-involved overdoses — opioids, stimulants, benzodiazepines, and polysubstance — and are dominated by synthetic opioids (fentanyl) in the 2020s. Excludes pure alcohol poisoning (tracked separately) and excludes deaths coded as intentional self-harm by drug poisoning (ICD-10 X60–X64), which fall under suicide, not accidental/undetermined overdose. The uncertainty band reflects the open question of whether the 2024–2025 decline holds: the low bound (~1 in 63) applies the lower 2025 provisional count (~69,973 deaths) over the same 59-year horizon, while the high bound (~1 in 42) retains headroom for a rebound toward the 2023 peak level, since a single low year compounded over a lifetime should not be treated as locked in.
Caveats: This is the fear on Likelier where the pooled lifetime number is least informati…
This is the fear on Likelier where the pooled lifetime number is least informative about any individual reader's actual risk. The distribution is sharply skewed on three axes at once. By age, deaths are concentrated in the 25–54 band, with rates falling off steeply after 65 and near-zero in childhood. By drug exposure, the single biggest predictor is prior opioid use — people with no history of non-medical opioid or stimulant use carry a small fraction of the pooled hazard, while people with opioid use disorder carry many multiples of it. By geography, county-level overdose mortality spans more than an order of magnitude, with Appalachian, Rust Belt, and West Coast metros far above the national average. The 1-in-42 figure is the right answer to "what is the average US adult's lifetime accidental overdose risk?" and the wrong answer to almost any more specific question. The 2023–2024 decline (the headline rate fell 26.2%) was also racially uneven: White and Black rates fell sharply — Black Americans saw the largest single-year drop (30.9%) — while American Indian and Alaska Native rates fell least (~20%) and remained the highest of any group at roughly 2.2× the national rate. So the overall improvement narrowed some gaps and widened others; the AI/AN disparity in particular persisted through the fourth-wave decline (CDC NCHS Data Brief 549, 2026). Note also that Likelier's number excludes deaths coded as intentional self-harm by drug poisoning (those live under suicide) and excludes pure alcohol poisoning (separate category).
Related risks
Other risks on similar themes — for exploring related fears.
Medication reaction
What are the odds of a serious adverse drug reaction from prescribed medication?
Benzo dependence
What are the odds of developing benzodiazepine dependence after a standard prescription?
Opioid addiction
What are the odds of developing opioid addiction after a standard surgical prescription?
Pick challenger
The magnitude here is the story, and so is the recent reversal. The US peak was 107,941 overdose deaths in 2022; 2023 came in at 105,007, and then 2024 broke the trend with 79,384 deaths — a 26.2% drop in the age-adjusted rate (31.3 → 23.1 per 100,000), the largest single-year decline the CDC has on record. Provisional 2025 data project a further ~14% fall to roughly 69,973 deaths — a third consecutive year of decline. Against a US adult population of roughly 260 million, the 2024 count works out to an annual accidental overdose hazard of about 3 per 10,000 adults. Compounded naively over 59 years of remaining adult life, the lifetime number now lands around 1 in 56 — down from the 1-in-42 figure built on the 2023 peak, but still in the same order of magnitude as dying in a car crash and roughly 5× higher than the lifetime odds of being murdered in the US. For working-age adults specifically, drug overdose has overtaken motor vehicle crashes as a cause of death in most recent years.
The composition of that number has shifted faster than almost any other mortality category. Synthetic opioids — essentially fentanyl and its analogues — drove both the run-up and the turnaround: fentanyl-involved deaths fell nearly 37% between 2023 and 2024, with cocaine and methamphetamine behind a stimulant share that declined more slowly, and benzodiazepines almost always present as a polysubstance co-factor rather than a lone cause. The decline is real and broad-based across drug categories and most states, but the post-2015 level shift is still well above the pre-fentanyl baseline; whether the lower 2024–2025 regime holds is the open question, which is why the lifetime band here keeps headroom for a rebound rather than collapsing onto a single low year.
What is unusual about this fear is how quietly it sits in most people’s heads. There is no Gallup tracker asking Americans how often they worry about dying of an overdose, because the survey designers, like most of the respondents, have filed it under “things that happen to other people”. The heterogeneity makes that half-true: by age, drug history, and geography, the actual risk spans more than two orders of magnitude, and the population-average 1-in-42 is not a personal forecast for anyone in particular. It is, however, the right number for the question “how common is this, really” — and the answer is: much more common than the near-absence of personal worry would suggest.
Related tidbits
Dying of an accidental drug overdose is about 7× more likely than being murdered over a US adult lifetime (~1 in 42 vs ~1 in 290). Overdose surpassed homicide nationally in the late 2010s and stayed there.
About 50% of lifelong smokers die from smoking. Drug overdose death odds are 1 in 42 over a lifetime. Smoking is legal, taxed, and sold at every gas station. One is a public health campaign. The other is a war.
The lifetime hazard of a US adult dying from an accidental drug overdose is about 1 in 42, comparable to many natural deaths and roughly 250× the mass-shooting baseline. Public ranking still puts it lower than both.
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
-
[1] CDC National Center for Health Statistics — Drug Overdose Deaths in the United States, 2023–2024 (NCHS Data Brief No. 549)
Drug Overdose Deaths in the United States, 2023–2024 (NCHS Data Brief No. 549)- Statistic
79,384 US drug overdose deaths in 2024; age-adjusted rate 23.1 per 100,000, down 26.2% from 31.3 in 2023; 2024 rate highest for American Indian/Alaska Native (51.6) and Black (33.8), lowest for Asian (4.4)- Excerpt
“"In 2024, 79,384 drug overdose deaths occurred, resulting in an age-adjusted rate of 23.1 deaths per 100,000 standard population… The largest decrease, 26.2%, occurred between 2023 and 2024, from 31.3 to 23.1… In 2024, the age-adjusted drug overdose death rate was highest for American Indian and Alaska Native non-Hispanic people (65.0 and 51.6, respectively) and lowest for Asian non-Hispanic people (5.1 and 4.4, respectively). The rate decreased most (30.9%) for Black non-Hispanic (subsequently, Black) people, from 48.9 to 33.8 deaths per 100,000 standard population between 2023 and 2024." ”
- Source data from
- 2026-01-01
- Accessed
- 2026-06-14 · archived copy
- Calculation
- Garnett MF, Miniño AM. Drug overdose deaths in the United States, 2023–2024. NCHS Data Brief. 2026 Jan;(549):1–13. This is the latest complete-year federal product on overdose mortality and supersedes Data Brief 522 (2023) for the headline figure. 79,384 deaths / ~260M US adults ≈ 0.000305 per adult-year; 1 − (1 − 0.000305)^59 ≈ 0.0179 ≈ 1 in 56. Race/ethnicity figures are age-adjusted rates per 100,000, the correct basis for between-group comparison; the AI/AN-to-national ratio (51.6 / 23.1 ≈ 2.23) and Black-to-national ratio (33.8 / 23.1 ≈ 1.46) feed the subgroup multipliers below.
- Independence
- NCHS Data Brief 549 is the primary federal product on 2024 overdose mortality, built directly from NVSS death-certificate records — the same pipeline as Data Brief 522 and NIDA's tracker. Treat as the authoritative count for the revised headline; the others remain as composition and coding-scope references.
-
[2] CDC National Center for Health Statistics — Drug Overdose Deaths in the United States, 2003–2023 (NCHS Data Brief No. 522)
Drug Overdose Deaths in the United States, 2003–2023 (NCHS Data Brief No. 522)- Statistic
105,007 US drug overdose deaths in 2023; age-adjusted rate 31.3 per 100,000 (down from 32.6 in 2022)- Excerpt
“"The age-adjusted rate of drug overdose deaths increased from 8.9 deaths per 100,000 standard population in 2003 to 32.6 in 2022; however, the rate decreased to 31.3 in 2023. After a period of increase between 2013 and 2022, rates of drug overdose deaths involving synthetic opioids other than methadone, which includes fentanyl, fentanyl analogs, and tramadol, decreased between 2022 and 2023." ”
- Source data from
- 2024-12-19
- Accessed
- 2026-04-11 · archived copy
- Calculation
- NCHS counts deaths from death certificates with an underlying cause coded as drug poisoning (ICD-10 X40–X44 accidental, X60–X64 intentional, X85 assault, Y10–Y14 undetermined). Likelier's normalized figure uses the accidental + undetermined portion, which is where ~90%+ of overdose deaths sit; intentional self-harm by drug poisoning is excluded here and lives under the suicide category. 105,007 deaths / ~258M US adults ≈ 0.000407 per adult-year; 1 − (1 − 0.000407)^59 ≈ 0.0237 ≈ 1 in 42. This documents the 2023 figure; the live headline was revised to the 2024 count in Data Brief 549 (above), and the uncertainty band is now derived there.
- Independence
- NCHS Data Brief 522 is the primary federal product on overdose mortality, built directly from NVSS death certificate records. NIDA's tracker (below) republishes and extends the same underlying NVSS data with drug-category breakdowns, so the two sources are partially dependent.
-
[3] National Institute on Drug Abuse (NIDA), NIH — Drug Overdose Deaths: Facts and Figures
Drug Overdose Deaths: Facts and Figures- Statistic
Over 105,000 US drug-involved overdose deaths in 2023; 107,941 in 2022; 79,358 opioid-involved; 72,776 synthetic-opioid-involved- Excerpt
“"Over 105,000 persons in the U.S. died from drug-involved overdose in 2023… Opioid-involved overdose deaths rose from 49,860 in 2019 to 81,806 in 2022 with a significant decrease to 79,358 in 2023… Drug overdose deaths involving synthetic opioids other than methadone (primarily fentanyl) decreased to 72,776 in 2023… In 2023, there were 10,870 drug overdose deaths involving benzodiazepines." ”
- Source data from
- 2024-08-01
- Accessed
- 2026-04-11 · archived copy
- Calculation
- NIDA's breakdown confirms that opioids (79,358) and specifically synthetic opioids (72,776) dominate the 2023 total, with stimulants (cocaine and methamphetamine combined, ~59,725 deaths, counted with substantial overlap) as the fast-growing second front. Benzodiazepines (10,870) are almost always part of a polysubstance mix rather than a lone cause. Used here to characterise the composition of the 105,007-death total rather than to recompute the headline number.
- Independence
- NIDA sources its figures from CDC WONDER / NVSS — same underlying data as the NCHS Data Brief — but provides the drug-category decomposition that NCHS headlines omit. Treat as a composition check, not an independent count.
-
[4] CDC National Center for Health Statistics / National Vital Statistics System — Vital Statistics Rapid Release — Provisional Drug Overdose Data
Vital Statistics Rapid Release — Provisional Drug Overdose Data- Statistic
VSRR publishes provisional 12-month ending overdose death counts, identified via ICD-10 codes X40–X44, X60–X64, X85, Y10–Y14- Excerpt
“"Final drug overdose death data are published annually through NCHS statistical reports and CDC WONDER. Drug overdose deaths are identified using underlying cause-of-death codes X40–X44 (unintentional), X60–X64 (suicide), X85 (homicide), and Y10–Y14 (undetermined) from the International Classification of Diseases, Tenth Revision." ”
- Source data from
- 2025-02-01
- Accessed
- 2026-04-11 · archived copy
- Calculation
- Cited to document the ICD-10 coding scope used throughout. The Likelier normalized figure explicitly excludes X60–X64 (intentional self-harm by drug poisoning) so that intent is not double-counted with the suicide category.
- Independence
- VSRR is the provisional front-end of the same NVSS death-certificate pipeline that feeds NCHS Data Brief 522 and NIDA's tracker; treat as a methodological reference for the ICD-10 coding scope rather than an independent count.